In another attempt to clarify the mechanism of CCN3 downregulation in CML, Suresh et al. assessed the role of MicroRNAs during BCR-ABL mediated signaling pathway. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.